Antlia Bioscience, Inc., 2026-06-05
An SEC Form D private-offering notice from Encinitas, CA, a $20,000,000 filer-stated offering target in Biotech. Filed 2026-06-05. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Develops novel long-acting peptide therapeutics for chronic cardiometabolic diseases using its PASylation platform.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Series 86-1, a series of StartEngine Private LLC, 2026-06-05, $3.9M, Burbank, CA
- Biostax Corp., 2026-06-08, $7.5M, Winter Park, FL
- Agility Retail Holdings LLC, 2026-06-05, $15M, San Francisco, CA
- Los Angeles Project Inc, 2026-06-05, $1.5M, Austin, TX
- Lightfighter, Inc., 2026-06-05, $2.5M, Felton, CA
- Spine BioPharma, Inc., 2026-06-05, $8.5M, New York, NY
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.